GENE THERAPY OF ADA DEFICIENT SCID
- 3 Anni 1999/2002
- 62.836€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- CURRENT OPINION IN MOLECULAR THERAPEUTICS
Advances in gene therapy for ADA-deficient SCID
- EXPERIMENTAL HEMATOLOGY
Administration of Flk2/Flt3 ligand induces expansion of human high-proliferative potential colony-forming cells in the SCID-hu mouse
- JOURNAL OF IMMUNOLOGY
IL-10 transgenic mice present a defect in T cell development reminiscent to SCID patients
- NATURE MEDICINE
Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice
